On the Effects of Glucagon-Like Peptide-1 on Blood Glucose Regulation in Normal and Diabetic Subjects
- 17 December 1996
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 805 (1) , 729-736
- https://doi.org/10.1111/j.1749-6632.1996.tb17549.x
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Ileal release of glucagon-like peptide-1 (GLP-1)Digestive Diseases and Sciences, 1995
- Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivoJournal of Clinical Endocrinology & Metabolism, 1995
- Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.Journal of Clinical Investigation, 1994
- Activity of oxyntomodulin on gastric acid secretion induced by histamine or a meal in the ratPeptides, 1994
- Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in manDigestive Diseases and Sciences, 1993
- Carboxypeptidase‐B‐like processing of the C‐terminus of glucagon‐like peptide‐2 in pig and human small intestineFEBS Letters, 1989
- Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.Journal of Clinical Investigation, 1987
- Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gutFEBS Letters, 1987
- Isolation of glucagon‐37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno‐ileumFEBS Letters, 1982
- Purification and chemical characterization of a glicentin-related pancreatic peptide (proglucagon fragment) from porcine pancreasBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982